Why the puberty blockers trial on 'trans' children is unethical and most be stopped

Arguments in favour of treatment are not based in science but are a consequence of damaging ideology

A controversial impending clinical trial on puberty blocking drugs in Britain will begin on Saturday to recruit hundreds of children as young as 11-years-old.

Legal challenge to King’s College London research study claimed it could harm participants but was rejected A clinical trial of drugs that can delay puberty can go ahead after a high court judge threw out a legal challenge on Friday. Campaigners had launched the attempt to halt the planned research into puberty blocker

Campaigners brought the legal action to try and stop the trial going ahead.

High Court gives green light to NHS puberty blocker trial for children  GB News

Campaigners wanted a judge to halt the 'deeply unethical and highly dangerous' trial, arguing regulators had acted unlawfully in approving it.

The High Court has ruled that the PATHWAYS puberty blockers trial can go ahead, after a judge threw out a challenge from campaigners. The challenge came from a number of groups or individuals, including the Bayswater Support Group which give “support for parents of children IDing as trans”. They asked that the trial be

The trial will see about 220 children treated with puberty-suppressing medication

A clinical trial into the benefits and risks of puberty blockers in teenagers is set to proceed after a legal challenge over the trial was thrown out by a High Court judge

The Good Law Project (GLP) has announced its intention to oppose a legal challenge mounted by the vehemently transphobic Bayswater Support Group against the upcoming puberty blocker trial for trans youth healthcare. Trans-led charity Gendered Intelligence will lead the case against Bayswater, should the need arise. On